Prelude Therapeutics Inc Quarterly Current Ratio in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Prelude Therapeutics Inc quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2024.
  • Prelude Therapeutics Inc Current Ratio for the quarter ending September 30, 2024 was 917 %, a 23% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 917 -274 -23% Sep 30, 2024
Q2 2024 1.08K -32.3 -2.91% Jun 30, 2024
Q1 2024 1.31K +222 +20.4% Mar 31, 2024
Q4 2023 1.23K -32.7 -2.59% Dec 31, 2023
Q3 2023 1.19K -242 -16.9% Sep 30, 2023
Q2 2023 1.11K -501 -31.1% Jun 30, 2023
Q1 2023 1.09K -689 -38.8% Mar 31, 2023
Q4 2022 1.26K -753 -37.3% Dec 31, 2022
Q3 2022 1.43K -728 -33.7% Sep 30, 2022
Q2 2022 1.61K -734 -31.3% Jun 30, 2022
Q1 2022 1.77K Mar 31, 2022
Q4 2021 2.02K Dec 31, 2021
Q3 2021 2.16K Sep 30, 2021
Q2 2021 2.34K Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.